Methods for regulating inflammatory mediators and peptides useful therein

Details for Australian Patent Application No. 2007223983 (hide)

Owner Biomarck Pharmaceuticals, Ltd. North Carolina State University

Inventors Parikh, Indu; Takashi, Shuji; Adler, Kenneth B.; Li, Yuehua; Martin, Linda D.

Agent Griffith Hack

Pub. Number AU-A-2007223983

PCT Pub. Number WO2007/103368

Priority 11/367,449 06.03.06 US

Filing date 6 March 2007

Wipo publication date 13 September 2007

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

Event Publications

25 September 2008 PCT application entered the National Phase

  PCT publication WO2007/103368 Priority application(s): WO2007/103368

16 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007223985-Quinazoline derivatives as phosphodiesterase 10 inhibitors

2007223981-HMG Co-A reductase inhibitor enhancement of bone and cartilage